A Phase Ib, Randomized, Observer-Blind, Multicenter, Factorial-Design Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Injections of Trivalent Inactivated Influenza Vaccine With or Without a Second Influenza B Strain in Combination With or Without One of Three Different Doses of Adjuvant in Healthy Children, Aged 6 to less than 36 Months.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary) ; Adjuvants
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Novartis
- 24 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2009 New trial record